![Hamzeh Abdul-Hadi](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hamzeh Abdul-Hadi
Private Equity Investor at Debiopharm Innovation Fund /Management/
Profile
Mr. Hamzeh Abdul-Hadi is an Associate at Hikma Ventures Ltd.
and a Research Analyst at Capital Investment & Brokerage Co.
Hamzeh Abdul-Hadi active positions
Companies | Position | Start |
---|---|---|
Debiopharm Innovation Fund /Management/
![]() Debiopharm Innovation Fund /Management/ Investment ManagersFinance Debiopharm Innovation Fund SA develops, manufactures, and markets diagnostic systems. It seeks to invest in the biotechnology, diagnostics, and pharmaceutical industries with a focus on biomarker development, and large molecule capabilities. The firm mission is to invest in innovative diagnostic companies developing platforms and content to complement in-house diagnostic activities, give insight into cutting-edge diagnostics and facilitate access to new technologies. The company was founded in 1979 and is headquartered in Fribourg, Switzerland. | Private Equity Investor | 30/06/2022 |
Former positions of Hamzeh Abdul-Hadi
Companies | Position | End |
---|---|---|
Capital Investment & Brokerage Co.
![]() Capital Investment & Brokerage Co. Investment Banks/BrokersFinance Capital Investment & Brokerage Co. is a broker/dealer headquartered in Amman, Jordan. It was founded in 19995 and is a subsidiary of Capital Bank of Jordan (ASE: EXFB). The firm provides a range of brokerage services to various clients. | Analyst-Equity | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Capital Investment & Brokerage Co.
![]() Capital Investment & Brokerage Co. Investment Banks/BrokersFinance Capital Investment & Brokerage Co. is a broker/dealer headquartered in Amman, Jordan. It was founded in 19995 and is a subsidiary of Capital Bank of Jordan (ASE: EXFB). The firm provides a range of brokerage services to various clients. | Finance |
Debiopharm Innovation Fund /Management/
![]() Debiopharm Innovation Fund /Management/ Investment ManagersFinance Debiopharm Innovation Fund SA develops, manufactures, and markets diagnostic systems. It seeks to invest in the biotechnology, diagnostics, and pharmaceutical industries with a focus on biomarker development, and large molecule capabilities. The firm mission is to invest in innovative diagnostic companies developing platforms and content to complement in-house diagnostic activities, give insight into cutting-edge diagnostics and facilitate access to new technologies. The company was founded in 1979 and is headquartered in Fribourg, Switzerland. | Finance |
- Stock Market
- Insiders
- Hamzeh Abdul-Hadi